Alise Reicin - Insider Trading & Ownership

Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Summary
The estimated net worth of Alise Reicin is at least $9.68M dollars as of September 29, 2025. Alise Reicin is the Chief Executive Officer, Director of Tectonic Therapeutic, Inc. and owns shares of Tectonic Therapeutic, Inc. (TECX) stock worth about $9.37M. Alise Reicin is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $309K.
Signature
/s/ Daniel Lochner, Attorney-in-Fact
All Insider Reports
All Insider Reports

Email me when Alise Reicin files a new Ownership 3,4,5 report.

⭐ Subscribe ⭐

Ownership of Alise Reicin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TECX Tectonic Therapeutic, Inc. Chief Executive Officer, Director $9.37M Sep 25, 2025
QTTB Q32 Bio Inc. Director $309K Jun 14, 2023
SANA Sana Biotechnology, Inc. Director Jun 5, 2025

Insider Transactions Reported by Alise Reicin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.